HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: CJN.03530708v1 4/2/337    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bolignano, D. Articles by Buemi, M. Search for Related Content PubMed PubMed Citation Articles by Bolignano, D. Articles by Buemi, M.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease

Davide Bolignano^*, Antonio Lacquaniti^*, Giuseppe Coppolino^*, Valentina Donato^*, Susanna Campo^*, Maria Rosaria Fazio^*, Giacomo Nicocia, and Michele Buemi^*

Departments of ^* Internal Medicine and Pathology and Experimental Microbiology, University of Messina, Messima, Italy

Correspondence: Dr. Michele Buemi, Via Salita Villa Contino, 30, 98100 Messina, Italy. Phone: +39090-2212265; Fax: +39090-2935162; E-mail: buemim{at}unime.it

Background and objectives: Chronic kidney disease (CKD) has recently assumed epidemic proportion, becoming a troubling emerging cause of morbidity, especially if it progresses to terminal stage (ESRD). The authors aimed to evaluate whether neutrophil gelatinase-associated lipocalin (NGAL), a novel specific biomarker of acute kidney injury, could predict the progression of CKD.

Design, setting, participants, & measurements: Serum and urinary NGAL levels, together with a series of putative progression factors, were evaluated in a cohort of 96 patients (mean age: 57 ± 16 years) affected by nonterminal CKD (eGFR 15 ml/min/1.73 m²) of various etiology. Progression of CKD, assessed as doubling of baseline serum creatinine and/or onset of ESRD, was evaluated during follow-up.

Results: At baseline, both serum and urinary NGAL were inversely, independently, and closely related to eGFR. After a median follow-up of 18.5 mo (range 1.01 to 20), 31 patients (32%) reached the composite endpoint. At baseline, these patients were significantly older and showed increased serum creatinine, calcium-phosphate product, C-reactive protein, fibrinogen, daily proteinuria, and NGAL levels, whereas eGFR values were significantly lower. Univariate followed by multivariate Cox proportional hazard regression analysis showed that urinary NGAL and sNGAL predicted CKD progression independently of other potential confounders, including eGFR and age.

Conclusion: In patients with CKD, NGAL closely reflects the entity of renal impairment and represents a strong and independent risk marker for progression of CKD.

This article has been cited by other articles:

				D. Bolignano, G. Coppolino, A. Romeo, L. De Paola, A. Buemi, A. Lacquaniti, G. Nicocia, L. Lombardi, and M. Buemi Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3398 - 3403. [Abstract] [Full Text] [PDF]

				M. Kasahara, K. Mori, N. Satoh, T. Kuwabara, H. Yokoi, A. Shimatsu, A. Sugawara, M. Mukoyama, and K. Nakao Reduction in urinary excretion of neutrophil gelatinase-associated lipocalin by angiotensin receptor blockers in hypertensive patients Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2608 - 2609. [Full Text] [PDF]

				D. Bolignano and M. Buemi Reply Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2609 - 2610. [Full Text] [PDF]